Ciltacabtagene autoleucel

cilta-cel · Janssen Biotech, Inc. / Legend Biotech Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ciltacabtagene autoleucel, covering 2024-10-26 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel [Phase 4]